Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydrocortisone Acetate Suppository in Hemorrhoidal Disease
NCT07909291Phase 2Not yet recruiting
- Sponsor
- Cristcot
- Start
- Sep 2026
- Primary completion
- Jan 2027
01
Overview
Phase 2, randomised, double-blind trial of hydrocortisone in hemorrhoidal disease (3 arms), sponsored by Cristcot. Primary endpoint: Hemorrhoid Disease Symptom & Impact Measure at 15 days. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
hydrocortisone
03
Conditions
hemorrhoidal disease
Beyond the preview
Go deeper on NCT07909291.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07909291.